nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute Kidney Injury Following Paracentesis Among Inpatients With Cirrhosis
|
Seethapathy, Harish |
|
|
5 |
8 |
p. 1305-1308 |
artikel |
2 |
An Unusual Case of Proteinuria in a Kidney Donor
|
Yadav, Anju |
|
|
5 |
8 |
p. 1360-1362 |
artikel |
3 |
A Pilot Study on the Effect of Prebiotic on Host-Microbial Co-metabolism in Peritoneal Dialysis Patients
|
Gao, Bei |
|
|
5 |
8 |
p. 1309-1315 |
artikel |
4 |
A Randomized Prospective Study Comparing Anti–T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients
|
Kamar, Nassim |
|
|
5 |
8 |
p. 1207-1217 |
artikel |
5 |
A Randomized Trial of Liposomal Prednisolone (LIPMAT) to Enhance Radiocephalic Fistula Maturation: A Pilot Study
|
Voorzaat, Bram M. |
|
|
5 |
8 |
p. 1327-1332 |
artikel |
6 |
Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis
|
Gipson, Debbie S. |
|
|
5 |
8 |
p. 1228-1239 |
artikel |
7 |
Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism
|
Kobayashi, Yusuke |
|
|
5 |
8 |
p. 1291-1297 |
artikel |
8 |
A Woman With “Polycystic Kidney Disease”
|
Tu, Yan |
|
|
5 |
8 |
p. 1367-1370 |
artikel |
9 |
Biological Efficacy and Safety of Niacinamide in Patients With ADPKD
|
El Ters, Mireille |
|
|
5 |
8 |
p. 1271-1279 |
artikel |
10 |
CKD and Pregnancy Outcomes in Africa: A Narrative Review
|
Maule, Sophie P. |
|
|
5 |
8 |
p. 1342-1349 |
artikel |
11 |
Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
|
Almaani, Salem |
|
|
5 |
8 |
p. 1302-1305 |
artikel |
12 |
Dashboards to Facilitate Nephrology Disaster Planning in the COVID-19 Era
|
Stevens, Jacob S. |
|
|
5 |
8 |
p. 1298-1302 |
artikel |
13 |
DNAJB11-Related Atypical ADPKD in a Kidney Transplant Donor
|
Wilson, Gregory J. |
|
|
5 |
8 |
p. 1363-1366 |
artikel |
14 |
Drug-Induced Thrombotic Microangiopathy Resulting in ESRD
|
Agarwal, Krishna A. |
|
|
5 |
8 |
p. 1350-1355 |
artikel |
15 |
Eculizumab and aHUS: Spotlight on Patient-Centered Care
|
Rafat, Cédric |
|
|
5 |
8 |
p. 1123-1125 |
artikel |
16 |
Epidemiological, Clinical, and Immunological Features of a Cluster of COVID-19–Contracted Hemodialysis Patients
|
Ma, Yiqiong |
|
|
5 |
8 |
p. 1333-1341 |
artikel |
17 |
Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens
|
Andeen, Nicole K. |
|
|
5 |
8 |
p. 1325-1327 |
artikel |
18 |
Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS Registry
|
Greenbaum, Larry A. |
|
|
5 |
8 |
p. 1161-1171 |
artikel |
19 |
Hierarchical Clustering Analysis for Predicting 1-Year Mortality After Starting Hemodialysis
|
Komaru, Yohei |
|
|
5 |
8 |
p. 1188-1195 |
artikel |
20 |
Immune Check Point Inhibitor–Associated Endothelialitis
|
Bobart, Shane A. |
|
|
5 |
8 |
p. 1371-1374 |
artikel |
21 |
Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
|
Herrmann, Sandra M. |
|
|
5 |
8 |
p. 1139-1148 |
artikel |
22 |
2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report
|
Li, Philip Kam-Tao |
|
|
5 |
8 |
p. 1129-1138 |
artikel |
23 |
Obesity-Related Glomerulopathy and Single-Nephron GFR
|
Denic, Aleksandar |
|
|
5 |
8 |
p. 1126-1128 |
artikel |
24 |
Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis
|
Robbins-Juarez, Shelief Y. |
|
|
5 |
8 |
p. 1149-1160 |
artikel |
25 |
Peritoneal Dialysis Catheter−Fallopian Tube Fistula
|
Mandalapu, Rajendra |
|
|
5 |
8 |
p. 1356-1359 |
artikel |
26 |
Postdischarge Health Care Costs and Readmission in Patients With Hyperkalemia-Related Hospitalizations
|
Betts, Keith A. |
|
|
5 |
8 |
p. 1280-1290 |
artikel |
27 |
Prevalence and Risk Factors of CKD in South Kivu, Democratic Republic of Congo: A Large-Scale Population Study
|
Masimango, Mannix Imani |
|
|
5 |
8 |
p. 1251-1260 |
artikel |
28 |
Reconsidering Genetic Testing for Neonatal Polycystic Kidney Disease
|
VanNoy, Grace E. |
|
|
5 |
8 |
p. 1316-1319 |
artikel |
29 |
Serum Uric Acid and Mortality Risk Among Hemodialysis Patients
|
Zawada, Adam M. |
|
|
5 |
8 |
p. 1196-1206 |
artikel |
30 |
Single-Nephron GFR in Patients With Obesity-Related Glomerulopathy
|
Okabayashi, Yusuke |
|
|
5 |
8 |
p. 1218-1227 |
artikel |
31 |
Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
|
Delafosse, Marion |
|
|
5 |
8 |
p. 1375 |
artikel |
32 |
Supervised Exercise Intervention and Overall Activity in CKD
|
Pike, Mindy M. |
|
|
5 |
8 |
p. 1261-1270 |
artikel |
33 |
The Authors Reply
|
Alberici, Federico |
|
|
5 |
8 |
p. 1376 |
artikel |
34 |
The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome
|
Mizuno, Hiroki |
|
|
5 |
8 |
p. 1172-1179 |
artikel |
35 |
Treatment of Nephrogenic Diabetes Insipidus Patients With cGMP-Stimulating Drugs Does Not Mitigate Polyuria or Increase Urinary Concentrating Ability
|
Hinrichs, Gitte R. |
|
|
5 |
8 |
p. 1319-1325 |
artikel |
36 |
Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD
|
Alencar de Pinho, Natalia |
|
|
5 |
8 |
p. 1240-1250 |
artikel |
37 |
Use of Desmopressin Prior to Kidney Biopsy in Patients With High Bleeding Risk
|
Leclerc, Simon |
|
|
5 |
8 |
p. 1180-1187 |
artikel |